Donald Trump’s executive order dismantling diversity, equity and inclusion efforts is making waves at international companies ...

Firms across various sectors are showing interest in expanding their domestic operations to appease the president. Analysts ...

Gene therapy has emerged as a promising approach to previously untreatable conditions, including Duchenne muscular dystrophy (DMD), a progressive disorder caused by DMD mutations that leads to early ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

It’s a city where students have marched in the streets to save two Picasso paintings from sale. It boasts the world’s oldest ...

That said, the financial results of both Apple and Amazon had some weaknesses under the hood. Apple's Services division, ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...

In theory, a lower-value dollar will boost exports from the US, but there is no guarantee that this will happen if reciprocal ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novartis AG (NOVN – Research Report), with a price target of CHF115.00. Protect Your ...

Though optimistic, speakers at the recent LSX World Congress in London, UK, recognised that recent turbulence in the wake of ...

The University of Liverpool and Swiss pharmaceutical giant Roche Diagnostics have launched a new Healthcare Charter ...

Hikers should consider visiting the Carpathian Alps, which includes Romania’s Transylvanian Alps, instead of the Swiss Alps. It’s not only a cost-effective option, but this mountain range has ...